SEARCH

SEARCH BY CITATION

References

  • 1
    Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: A review. Arch Intern Med 2001; 161: 525533.
  • 2
    Bartlett JG, Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334339.
  • 3
    Riddle DJ, Dubberke ER. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13: 592600.
  • 4
    Dubberke ER, Burdette SD. Clostridium difficile infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): S42S49.
  • 5
    Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 17411751.
  • 6
    Carbone J, Sarmiento E, Palomo J, et al. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc 2007; 39: 23852388.
  • 7
    Collini PJ, Bauer M, Kuijper E, Dockrell DH. Clostridium difficile infection in HIV-seropositive individuals and transplant recipients. J Infect 2012; 64: 131147.
  • 8
    Pant C, Anderson MP, O'Connor JA, Marshall CM, Deshpande A, Sferra TJ. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: Results from the 2009 Nationwide Inpatient Sample database. Transpl Infect Dis 2012; 14: 540547.
  • 9
    Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 10791087.
  • 10
    Mehta AK. Suggested therapy of Clostridium difficile colitis after transplantation. In: Lombard GA, LaPlace SG, Taylor DE, Valentine VG, eds. The AST handbook of transplant infections. Hoboken, NJ: Blackwell Publications, 2011, p. 80.
  • 11
    Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: Case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580585.
  • 12
    Kumar D, Humar A, Ebrary, Inc., American Society of Transplantation. Infectious Diseases Community of Practice. The AST handbook of transplant infections. Hoboken, NJ: Blackwell Publications, 2011.
  • 13
    Weingarden AR, Hamilton MJ, Sadowsky MJ, Khoruts A. Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. J Clin Gastroenterol 2013; 47: 735737.
  • 14
    Ihunnah C. Fecal microbiota transplantation (FMT) for treatment of Clostridium difficile infection (CDI) in immunocompromised patients. Paper presented at the 2013 ACG Governors Award Recipients for Excellence in Clinical Research; ACG 2013 Annual Scientific Meeting; October 11–16; San Diego, CA.
  • 15
    Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354360.
  • 16
    Tosh PK, McDonald LC. Infection control in the multidrug-resistant era: Tending the human microbiome. Clin Infect Dis 2012; 54: 707713.
  • 17
    Gunderson CC, Gupta MR, Lopez F, et al. Clostridium difficile colitis in lung transplantation. Transpl Infect Dis 2008; 10: 245251.
  • 18
    Alegre ML, Bartman C, Chong AS. Microbes and allogeneic transplantation. Transplantation 2014; 9: 511.